News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Culwell Kelly
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Granted 150,000 options to buy
@ $3.25, valued at
$487.5k
|
|
| 06/08/2020 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 31,548 shares
@ $3.31, valued at
$104.4k
|
|
| 05/26/2020 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 39,435 shares
@ $4.99, valued at
$196.8k
|
|
| 05/08/2020 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 7,792 shares
@ $5.24, valued at
$40.8k
|
|
| 05/01/2020 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Sold 1,000 shares
@ $4.66, valued at
$4.7k
Sold 1,000 shares
@ $4.75, valued at
$4.8k
|
|
| 02/21/2020 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Sold 1,000 shares
@ $7, valued at
$7k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2019 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Sold 1,000 shares
@ $7.35, valued at
$7.4k
|
|
| 11/26/2019 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 5,187 shares
@ $6.22, valued at
$32.3k
|
|
| 11/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2019 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 864 shares
@ $5.13, valued at
$4.4k
|
|
| 06/12/2019 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 5,187 shares
@ $6.36, valued at
$33k
|
|
| 04/03/2019 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 1,022 shares
@ $3.55, valued at
$3.6k
|
|
| 11/29/2018 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted options to buy
@ $3.45, valued at
$0 |
|
| 08/20/2018 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 3,000 shares
@ $2.24, valued at
$6.7k
|
|
| 07/03/2018 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 13,733 shares
@ $0
Paid exercise price by delivering 4,748 shares
@ $2.46, valued at
$11.7k
|
|
| 03/14/2018 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 260,000 options to buy
@ $7.29, valued at
$1.9M
|
|
| 01/18/2018 |
4
| Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 7,699 options to buy
@ $46.36, valued at
$356.9k
|
|
|
|